| Product NDC: | 55154-3650 |
| Proprietary Name: | Skelaxin |
| Non Proprietary Name: | Metaxalone |
| Active Ingredient(s): | 800 mg/1 & nbsp; Metaxalone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-3650 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013217 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020830 |
| Package NDC: | 55154-3650-1 |
| Package Description: | 100 TABLET in 1 BOTTLE (55154-3650-1) |
| NDC Code | 55154-3650-1 |
| Proprietary Name | Skelaxin |
| Package Description | 100 TABLET in 1 BOTTLE (55154-3650-1) |
| Product NDC | 55154-3650 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metaxalone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020830 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | METAXALONE |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |